Trial intelligence / Profile preview

P1060: NNRTI vs PI-based ART in HIV-Infected Infants

NCT00307151Phase 2Completed

Sponsor
IMPAACT Network
Start
Dec 2005
Primary completion
Dec 2010
Modality
Small Molecules
Countries
7
01

Overview

A Phase 2 trial of lopinavir + ritonavir in human immunodeficiency virus infection (HIV), sponsored by IMPAACT Network. Started Dec 2005; status: completed.

02

Drugs

lopinavir + ritonavir
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT00307151.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00307151.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call